Loading company…
mbiomics researches microbiome-based therapies and provides microbiome analysis and monitoring products.
Founded in 2020, mbiomics is a biotechnology company based in Munich, Germany. Its products include microbiome profiling and monitoring tools and the Stratos platform, which combines biomarker panels and turnaround times. The company was co-founded by Laura Figulla, Markus Rinecker, Johannes B. Woehrstein, and Heinrich Grabmayr. In April 2026, it raised EUR 12 million from MIG Capital and Bayern Kapital to expand investigational new drug-enabling data and prepare for clinical evaluation.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in